Andy Sassine - Aug 15, 2025 Form 4/A - Amendment Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Role: Chief Financial Officer, Director
Signature: /s/ Ilan Katz, attorney-in-fact
Stock symbol: ARCT
Transactions as of: Aug 15, 2025
Transactions value $: $20,499
Form type: 4/A - Amendment
Date filed: 8/20/2025, 04:01 PM
Date Of Original Report: Aug 19, 2025
Previous filing: Jul 17, 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
SASSINE ANDY	Chief Financial Officer, Director	C/O ARCTURUS THERAPEUTICS HOLDINGS INC., 10628 SCIENCE CENTER DRIVE, SUITE 250, SAN DIEGO	/s/ Ilan Katz, attorney-in-fact	2025-08-20	0001515322

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARCT	Common Stock	Purchase	$20.5K	+1.24K	+0.56%	$16.56	222K	Aug 15, 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The purchase reported on this Form 4 was effected by the Reporting Person pursuant to the Arcturus Therapeutics Holdings Inc. 2020 Employee Stock Purchase Plan (the "ESPP").
F2	In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on August 15, 2025.